Sharecare, a digital health company, has launched its Sharecare YOU desktop app, a 3D simulation of the human body, aimed at improving science, health, and medical education from elementary grades to higher education and beyond, it was reported on Wednesday.
The company has added Sharecare YOU to its content and virtual health engagement platform, using virtual reality and allowing users, including students, teachers, and parents, to access its interactive photorealistic elements directly from their computers for the first time.
Sharecare YOU provides photorealistic visualisations enabling users to explore the human body in the highest resolution and 360-degree detail. It offers educational visualisations of the organs and anatomy associated with the cardiovascular, digestive/gastrointestinal, nervous, reproductive, respiratory, and urinary systems. It is offered for PC or Mac in Steam, the Microsoft Store, and the App Store in two versions, a standard one, optimised for students and consumers for USD29.99, and a pro version designed for educators for USD269.99.
Merck completes acquisition of Verona Pharma to expand cardio-pulmonary portfolio
Amgen offers Repatha through AmgenNow direct-to-patient programme
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Early, Evidence-Led Cardiovascular Care Strengthened in High-Risk MENA Regions
Corstasis and U.S. Heart and Vascular partner to advance heart failure care with ENBUMYST
Eli Lilly and Company's orforglipron outperforms oral semaglutide in Phase 3 ACHIEVE-3 trial
Merck reports positive Phase 3 results for oral PCSK9 inhibitor enlicitide
Abbott's Navitor TAVI system granted CE Mark for expanded indication
Cereno Scientific receives FDA Fast Track designation for CS1 in pulmonary arterial hypertension
FDA lifts clinical hold on Rocket Pharmaceuticals' RP-A501 Phase 2 Danon disease trial
OptiBiotix signs distribution deal with major weight management company
Novartis to present cardiovascular abstracts portfolio data at ESC Congress in Madrid
LivaNova announces commercial launch of Essenz Perfusion System in China